We have shown previously that transition from compensatory cardiac hypertrophy to de-compensatory heart failure is mainly due to decreased angiogenesis due to increased anti-angiogenic factors like angiostatin, endostatin and parstatin (1, 2, 16) . This evidence concerns the gene COL18A1 and cardiac hypertrophy.